UVAYIAITTDMLJY-UHFFFAOYSA-N
C37H39F3N8O5 — CID 59711957
Data last refreshed: (MolForge compound catalog, from PubChem)
About UVAYIAITTDMLJY-UHFFFAOYSA-N
UVAYIAITTDMLJY-UHFFFAOYSA-N (PubChem CID 59711957) has the molecular formula C37H39F3N8O5 and a molecular weight of 732.76 g/mol. Its IUPAC name is N-[3-methoxy-5-[7-(4-morpholin-4-ylanilino)-1-(2-morpholin-4-ylethyl)-2-oxo-4H-pyrimido[4,5-d]pyrimidin-3-yl]phenyl]-3-(trifluoromethyl)benzamide.
Molecular Properties
| Compound Name | UVAYIAITTDMLJY-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 59711957 |
| Molecular Formula | C37H39F3N8O5 |
| Molecular Weight | 732.76 g/mol |
| Exact Mass | 732.30 |
| IUPAC Name | N-[3-methoxy-5-[7-(4-morpholin-4-ylanilino)-1-(2-morpholin-4-ylethyl)-2-oxo-4H-pyrimido[4,5-d]pyrimidin-3-yl]phenyl]-3-(trifluoromethyl)benzamide |
| SMILES | COc1cc(NC(=O)c2cccc(C(F)(F)F)c2)cc(N2Cc3cnc(Nc4ccc(N5CCOCC5)cc4)nc3N(CCN3CCOCC3)C2=O)c1 |
| InChI | InChI=1S/C37H39F3N8O5/c1-51-32-21-29(42-34(49)25-3-2-4-27(19-25)37(38,39)40)20-31(22-32)48-24-26-23-41-35(43-28-5-7-30(8-6-28)46-13-17-53-18-14-46)44-33(26)47(36(48)50)10-9-45-11-15-52-16-12-45/h2-8,19-23H,9-18,24H2,1H3,(H,42,49)(H,41,43,44) |
| InChIKey | UVAYIAITTDMLJY-UHFFFAOYSA-N |
| XLogP | 5.62 |
| TPSA | 124.63 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 53 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 732.76 |
| LogP ≤ 5 | 5.62 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 59711957 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.